“…The adverse outcomes studied included mortality (nine studies) [ 33 , 34 , 35 , 36 , 37 , 38 , 40 , 43 , 45 ], transfer to ICU (one study) [ 36 ], length of hospital stay (one study) [ 46 ], invasive mechanical ventilation (IMV) (one study) [ 20 ], non-invasive mechanical ventilation failure (NIMVF) (one study) [ 44 ], pulmonary hypertension (one study) [ 39 ], and composite endpoints (two studies: ICU admission or death; one study: ICU admission, IMV, or death) [ 32 , 41 , 42 ]. Seven studies investigated in-hospital mortality [ 32 , 34 , 35 , 38 , 40 , 41 , 42 ], three 28-day mortality [ 36 , 43 , 45 ], and two 90-day mortality [ 33 , 37 ]. Eight studies were conducted in China [ 36 , 37 , 39 , 42 , 43 , 44 , 45 , 46 ], two in Iran [ 34 , 40 ], two in Turkey [ 35 , 38 ], one in Egypt [ 32 ], one in Australia [ 33 ], and one in Colombia [ 41 ] ( Table 1 ).…”